Future Clinical Trial Designs
This group explores all literacy and advocacy related to biomedical clinical trials. Conversations and... View more
Organizer:
- Organized by
-
-
HIV Care
-
HIV Care
The HVTN 505 approach to the changing HIV prevention landscape provided a lot of insight. We know the IPM Dapivirine Vaginal ring received positive opinion from EMA. What do you think if it were approved as a new HIV prevention tool for women during the PrEPVacc trial?
-
1 Reply
-
That would be interesting to observe! However, if provided as part of the study design, women would choose between taking a pill and using a ring. Similar to what is being done under the REACH trial, 6 months on pills and 6 months on the ring followed by a crossover.
The forum ‘Clinical Trial Design’ is closed to new discussions and replies.